Welcome to BioLegend’s one-of-a-kind advanced search. Search by any one of the single fields below or narrow down your searches by using multiple parameters. Looking for an anti-mouse NK cell antibody for IHC? Or looking for a FITC-conjugated antibody against a human marker for dendritic cells to use for flow cytometry? Only BioLegend’s advanced search can provide you with the best answers. If you have further questions, please contact our technical service team at 858-768-5801.
Use this document lookup tool to find Current Product Datasheets, Certificates of Analysis, or MSDS for any antibody products you have purchased from BioLegend.
Use the search box below to perform a site search of BioLegend.com powered by Google™.
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™ under optimal conditions. The solution is free of unconjugated Brilliant Violet 421™ and unconjugated antibody.
Storage & Handling:
The antibody solution should be stored undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining, the suggested use of this reagent is ≤5 µl per million cells or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.
ELISA1-4,11,14 or ELISPOT5 Detection: The biotinylated XMG1.2 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with purified R4-6A2 antibody (Cat. No. 505702/505706) as the capture antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard. ELISA or ELISPOT Capture: The purified XMG1.2 antibody is useful as a capture antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated R4-6A2 antibody (Cat. No. 505704) as the detection antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard. The LEAF™ purified antibody is suggested for ELISPOT capture (Cat. No. 505812). Flow Cytometry7,8,12,13,16: The fluorochrome-labeled XMG1.2 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-γ-producing cells within mixed cell populations. View intracellular cytokine staining protocol Neutralization1-3,9,10: The XMG1.2 antibody can neutralize the bioactivity of natural or recombinant IFN-γ. The LEAF™ purified antibody (Endotoxin <0.1 EU/μg, Azide-Free, 0.2 μm sterile-filtered) is recommended for neutralization of mouse IFN-γ bioactivity in vivo and in vitro (Cat. No. 505812). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 505834) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg). Additional reported applications (for the relevant formats) include: Western blotting, immunohistochemical staining of paraformaldehyde-fixed, saponin-treated frozen tissue sections6, and immunocytochemistry. Note: For testing mouse IFN-γ in serum, plasma or supernatant, BioLegend's ELISA Max™ Sets (Cat. No. 430801 to 430806) are specially developed and recommended.
Application References:
1. Abrams J, et al. 1992. Immunol. Rev. 127:5. (ELISA, Neut) 2. Sander B, et al. 1993. J. Immunol. Meth. 166:201. (ELISA, Neut) 3. Abrams J, et al. 1995. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.20. (ELISA, Neut) 4. Yang X, et al. 1993. J. Immunoassay 14:129. (ELISA) 5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.19. (ELISPOT) 6. Sander B, et al. 1991. Immunol. Rev. 119:65. (IHC) 7. Ferrick D, et al. 1995. Nature 373:255. (FC) 8. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed 9. Peterson KE, et al. 2000. J. Virol. 74:5363. (Neut) 10. DeKrey GK, et al. 1998. Infect. Immun. 66:827. (Neut) 11. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA) 12. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC) 13. Lee JW, et al. 2006. Nature Immunol. 8:181. (FC) PubMed 14. Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed 15. Montfort M, et al.2004. J. Immunol. 173:4084. PubMed 16. Haring JS, et al. 2008. J. Immunol. 180:2855. (FC) PubMed 17. Jordan JM, et al. 2008. Infect Immun. 76:3717. PubMed 18. Tonkin DR, et al. 2008. J. Immunol. 181:4516. PubMed 19. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed 20. Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (FC) PubMed
C57BL/6 mouse splenocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD3 FITC, fixed, permeabilized, and then stained with IFN-γ (clone XMG1.2) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).
Interferon-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells. The XMG1.2 antibody reacts with mouse interferon-γ (IFN-γ).
Other Names:
Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF), IFN-g, IFN-gamma
Structure:
Cytokine; dimer; 40-80 kD (Mammalian)
Regulation:
Upregulated by IL-2, FGF-basic, EGF; downregulated by 1-α-25-Dihydroxy vitamin D3, dexamethasone
Cellular Sources:
CD8+ and CD4+ T cells, NK cells
Cellular Targets:
T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
Receptors:
IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
Bioactivity/Activities:
Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APCs
Antigen References:
1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press, San Diego. 2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321. 3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571. 4. Gray P, et al. 1987. Lymphokines 13:151.
*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.
APC anti-mouse IFN-γ
PMA/Ionomycin-stimulated (6hrs) C57BL/6 mouse splenocytes stained with XMG1.2 APC and B220 (RA3-6B2) PE
Biotin anti-mouse IFN-γ
FITC anti-mouse IFN-γ
PMA/Ionomycin-stimulated BALB/c
T cells were stained with CD3 FITC
and XMG1.2 PE
LEAF™ Purified anti-mouse IFN-γ
PE anti-mouse IFN-γ
PMA/Ionomycin-stimulated BALB/c
T cells were stained with CD3 FITC
and XMG1.2 PE
Purified anti-mouse IFN-γ
Alexa Fluor® 488 anti-mouse IFN-γ
PMA+Ionomycin-stimulated (6hrs) Balb/c mouse splenocytes surface stained with CD3 (145-2C11) APC and intracellular stained with XMG1.2 Alexa Fluor® 488
Pacific Blue™ anti-mouse IFN-γ
PMA and Ionomycin-stimulated (6hrs) BALB/c splenocytes stained with XMG1.2 Pacific Blue™
and CD3 PE
PerCP/Cy5.5 anti-mouse IFN-γ
PMA/Ionomycin-stimlated ( 6hrs ) C57BL/6 splenocytes surface stained with 145-2C11 (CD3) APC and intracellularly stained with XMG1.2 PerCP/Cy5.5
PE/Cy7 anti-mouse IFN-γ
PMA/Ionomycin-stimulated (6hrs) C57BL/6 mouse splenocytes stained with B220 (RA3-6B2) APC and XMG1.2 PE/Cy7
Brilliant Violet 421™ anti-mouse IFN-γ
C57BL/6 mouse splenocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD3 FITC, fixed, permeabilized, and then stained with IFN-γ (clone XMG1.2) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).
Brilliant Violet 650™ anti-mouse IFN-γ
PMA + Ionomycin-stimulated (6 hours) C57BL/6 mouse splenocytes (in the presence of monensin) were stained with CD3 PE, fixed, permeabilized, and then stained with IFN-γ (clone XMG1.2) Brilliant Violet 650™.
